CartiHeal Announces Positive Interim Results of Agili-C IDE Study
CartiHeal announced that per the results of an interim analysis of the IDE study of Agili-C™ in the treatment of cartilage lesions, trial enrollment will stop at 250 subjects. Dec 09, 2019